Skip to main navigation Skip to search Skip to main content

Mitochondria-targeting cyclometallated rhodium(iii) complexes appended with two rhodamine units as Type I photosensitisers for bioimaging and photocytotoxicity applications by inducing pyroptosis

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

1 Downloads (CityUHK Scholars)

Abstract

Cyclometallated rhodium(iii) complexes have been underexplored as photosensitisers due to their low-lying d–d excited states, which result in weak visible-light absorption and non-emissive properties, coupled with a modest heavy atom effect that limits reactive oxygen species (ROS) generation. In this work, a series of cyclometallated rhodium(iii) polypyridine complexes appended with two rhodamine units [Rh(N^C)2(bpy-diRho)](PF6)3 was rationally designed as Type I photosensitisers. These complexes exhibited intense absorption in the visible region and moderate rhodamine fluorescence in solution upon photoexcitation. Time-resolved transient absorption spectroscopy revealed a long-lived rhodamine-based triplet excited state as the lowest-lying excited state in this hybrid system, which is attributed to the presence of the rhodium(iii) centre and is responsible for ROS photosensitisation. Notably, these rhodium(iii) complexes efficiently generated superoxide anion (O2˙−) and hydroxyl (HO˙) radicals via the Type I pathway upon photoirradiation, likely via intramolecular electron transfer between the two adjacent excited rhodamine units within the complex to form radical cation and anion. Cellular colocalisation studies demonstrated that these complexes predominantly accumulated in mitochondria, where the photosensitised ROS triggered significant mitochondrial dysfunction, resulting in their outstanding photocytotoxicity under both normoxic and CoCl2-induced hypoxic conditions. Further mechanistic investigations revealed that the photoinduced mitochondrial ROS generation triggered cancer cell death via gasdermin D-mediated pyroptosis. This rhodium(iii)–dirhodamine system further explores the utilisation of rhodium(iii) complexes as phototheranostic agents and underscores their potential in this role. This journal is © The Royal Society of Chemistry, 2026
Original languageEnglish
Pages (from-to)8197-8207
Number of pages11
JournalChemical Science
Volume17
Issue number16
Online published5 Mar 2026
DOIs
Publication statusPublished - 29 Apr 2026

Funding

We thank the Hong Kong Research Grants Council (project no. CityU 11317022, CityU 11309423, CityU 11304524 and C7075-21GF), the Hong Kong Research Grants Council and National Natural Science Foundation of China (project no. N_CityU104/21), the National Natural Science Foundation of China (grant no. 21771099) and the Science, Technology and Innovation Commission of Shenzhen Municipality (grant no. JCYJ20190809165411528) for financial support. We also acknowledge funding support from the “Laboratory for Synthetic Chemistry and Chemical Biology” under the Health@InnoHK Programme launched by Innovation and Technology Commission, the Government of Hong Kong SAR, P. R. China. We are also grateful to Dr Jie Wang for his help in biological studies. K. G.-M. J. acknowledges the receipt of a Postgraduate Studentship administered by City University of Hong Kong and Southern University of Science and Technology.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Publisher's Copyright Statement

  • This full text is made available under CC-BY-NC 4.0. https://creativecommons.org/licenses/by-nc/4.0/

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'Mitochondria-targeting cyclometallated rhodium(iii) complexes appended with two rhodamine units as Type I photosensitisers for bioimaging and photocytotoxicity applications by inducing pyroptosis'. Together they form a unique fingerprint.

Cite this